Modulation of Amyloid-β and tau in Alzheimer’s disease plasma neuronal-derived extracellular vesicles by Cerebrolysin® and donepezil

Manuscript Number: 

22-0575R1

Author(s): 
Manuel Aleixandre, Irene Alvarez, X. Anton Alvarez, James W. Barlow, Manuel García-Fantini, Birgit Kastberger, Carlos Linares, Robert A. Rissman, Floyd Sarsoza, Charisse N. Winston, Stefan Winter

Disclosures

Manuel Aleixandre

  • Nothing to Disclose

X. Anton Alvarez

  • Lecture Fees:
    Travel grants and speakers' honoraria for the participation in symposia sponsored by EVER Neuro Pharma GmbH in 2019
    Grants
    • Agency: 
      Ever NeuroPharma GmbH
      Dates: 
      2014-2018
    • Agency: 
      Oryzon Genomics
      Dates: 
      2018-2021
    • Agency: 
      Heptares Therapeutics LTD
      Dates: 
      2017-2020

Irene Alvarez

  • Nothing to Disclose

James W. Barlow

  • Nothing to Disclose

Manuel García-Fantini

  • Nothing to Disclose

Birgit Kastberger

  • Sponsors:
    EVER Neuro Pharma GmbH

Carlos Linares

  • Nothing to Disclose

Robert A. Rissman

  • Nothing to Disclose

Floyd Sarsoza

  • Nothing to Disclose

Charisse N. Winston

  • Nothing to Disclose

Stefan Winter

  • Sponsors:
    EVER Neuro Pharma GmbH